SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending after its Q4 earnings report, which largely surpassed estimates, yet the stock saw a significant decline. Community discussion is polarized, with bulls viewing the dip as an oversold opportunity, highlighting strong subscriber growth and accelerating ad revenue. Conversely, bears are focused on cautious forward guidance, increased content spending, and the pause in share buybacks tied to a potential major acquisition, fueling concerns about near-term shareholder value.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is experiencing a powerful rally to record highs, driven by heightened geopolitical tensions, particularly concerns surrounding President Trump's tariff threats against European allies over Greenland. The community is actively discussing gold's role as a vital safe-haven, with many viewing it as a critical hedge against market instability and potential dollar weakness in a "risk-off" environment. This reflects a broad shift towards tangible assets amidst global uncertainty.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is driving significant conversation due to recent analyst upgrades and reports of a substantial U.S. SHIELD defense contract, further highlighting its strategic importance in domestic chip manufacturing. The community is actively discussing expectations for an upcoming earnings report, with sentiment boosted by reports of Intel's 2026 server CPU capacity being largely sold out amidst growing AI demand.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is trending due to surging natural gas futures prices, driven by forecasts of an extensive arctic cold snap and polar vortex across the US. This weather-driven demand is igniting a significant short squeeze, with the community actively discussing potential further upside and extreme volatility for leveraged natural gas products.

America's Oil Reserve for the Digital Age

U.S Oil

USOR CRYPTO is experiencing extreme volatility and highly polarized community sentiment, with many labeling it a 'rug pull' or 'pump and dump' after sharp price movements. Despite these strong warnings, a segment of the community remains aggressively bullish, anticipating massive gains and a significant event by early February. The ongoing debate also highlights widespread confusion and questions regarding legitimate buying avenues and potential fake tokens.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals (CRVS) is trending due to impressive Phase 1 clinical trial data for its atopic dermatitis drug, soquelitinib, which demonstrated strong efficacy and a favorable safety profile, particularly in treatment-resistant patients. While many in the community are excited about the drug's potential and prospects for future partnerships, a significant public offering has sparked debate regarding immediate dilution versus funding crucial advancements through later-stage trials.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is experiencing extreme volatility and a significant decline, as natural gas prices surge on forecasts predicting colder U.S. weather and heightened heating demand, triggering a notable short squeeze. The community is actively discussing KOLD's dramatic daily drops and the rapid ascent of its inverse, highlighting the "widowmaker" nature of natural gas markets as traders navigate this weather-driven rally.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as recent comments from its CEO about "agonizingly slow" initial production for Cybercab and Optimus intensify bear arguments regarding unfulfilled promises and declining sales. The community is actively debating the stock's future ahead of upcoming earnings, with sentiment also shaped by increasing EV competition and potential geopolitical impacts from tariff discussions, leading to highly volatile trading.

SSgA Active Trust - State Street Consumer Staples Select Sector SPDR ETF

Consumer Staples Select Sector SPDR Fund

The Consumer Staples Select Sector SPDR Fund (XLP) is trending as investors increasingly seek defensive assets, positioning it as a safe haven amidst broader market uncertainties. The community is actively discussing a significant sector rotation, with XLP experiencing a notable rally and challenging key technical resistance levels after a period of underperformance. Many view this shift as smart money moving into "risk-off" assets, highlighting the sector's potential for stability and continued upside.

Constellation Software Inc

Constellation Software (CSU.TSX) is a major talking point amid its deepest historical drawdown, sparking intense debate among investors. While many view the current valuation as an attractive buying opportunity, bolstered by recent strong financial results and analyst support, others are concerned about the broader impact of AI on the software sector, questioning the stock's immediate recovery potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FDA Signals Support For Mesoblast's Cell Therapy For Chronic Back Pain

Mesoblast says FDA feedback supports filing plans for its cell therapy to treat chronic back pain, showing reduced pain and lower opioid use in a late-stage trial.read more...

Mesoblast (NASDAQ:MESO) Shares Gap Down - Time to Sell?

Mesoblast (NASDAQ:MESO) Shares Gap Down - Should You Sell...

Mesoblast Chair Jane Bell To Retire; Appoints Philip Facchina As Non-executive Chair

(RTTNews) - Mesoblast Limited (MESO, MSB.AX) announced that Jane Bell will retire from her role as Chair and will remain on the Board as a non-executive director. The Board has unanimously appointed...

Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy

Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy PR Newswire VANCOUVER, BC, Dec. 16, 2025 Issued on behalf of Avant...

Mesoblast (NASDAQ:MESO) Shares Gap Up - What's Next?

Mesoblast (NASDAQ:MESO) Shares Gap Up - Here's What Happened...

Mesoblast (NASDAQ:MESO) Stock Price Passes Below 50-Day Moving Average - Here's Why

Mesoblast (NASDAQ:MESO) Shares Pass Below 50-Day Moving Average - What's Next...

Mesoblast (NASDAQ:MESO) Shares Gap Up - Here's Why

Mesoblast (NASDAQ:MESO) Shares Gap Up - What's Next...

Mesoblast Appoints James M O'Brien New CFO

(RTTNews) - Mesoblast Ltd. (MESO, MSB.AX), an Australian regenerative medicine company, Monday announced the appointment of James M O'Brien as its US-based Chief Financial Officer or CFO. The company...

Bears are Losing Control Over Mesoblast Limited (MESO), Here's Why It's a 'Buy' Now

After losing some value lately, a hammer chart pattern has been formed for Mesoblast Limited (MESO), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

All You Need to Know About Mesoblast Limited (MESO) Rating Upgrade to Buy

Mesoblast Limited (MESO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

Mesoblast Ltd - ADR

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Current Price	$16.83
Prev Close	$17.45
Open	$17.10
Dividend Yield	0.00%
50-Day Moving Average	$17.43
Beta	1.40
Avg. Volume	224,921.36
PE Ratio	-19.90

52-Week High	$21.50
52-Week Low	$9.61
Market Capitalization	$2.17B
EPS (Annual)	-$0.8443
Price to Book	3.61
Revenue Per Employee	$211,960.04
Enterprise Value/EBITDA	N/A

MESO
Mesoblast limited.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MESO News

MESOMesoblast limited.